Cargando…

Progress toward therapeutic potential for AFQ056 in Fragile X syndrome

Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading single-gene cause of autism. It is caused by the lack of production of the Fragile X mental retardation protein (FMRP), resulting in cognitive deficits, hyperactivity, and autistic behaviors. Breakt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sourial, Mary, Cheng, Connie, Doering, Laurie C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863540/ https://www.ncbi.nlm.nih.gov/pubmed/27186135 http://dx.doi.org/10.2147/JEP.S27044

Ejemplares similares

Astrocytes and Developmental Plasticity in Fragile X
por: Cheng, Connie, et al.
Publicado: (2012)

Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis
por: Negida, Ahmed, et al.
Publicado: (2021)

Astrocyte-Secreted Factors Selectively Alter Neural Stem and Progenitor Cell Proliferation in the Fragile X Mouse
por: Sourial, Mary, et al.
Publicado: (2016)

The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro
por: Tabolacci, Elisabetta, et al.
Publicado: (2012)

Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model
por: Cheng, Connie, et al.
Publicado: (2016)

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
por: Wang, Hansen, et al.
Publicado: (2015)

Cross-Cultural Differences and Psychometric Properties of the Japanese Actions and Feelings Questionnaire (J-AFQ)
por: Huggins, Charlotte F., et al.
Publicado: (2021)

Involvement and Therapeutic Potential of the GABAergic System in the Fragile X Syndrome
por: Heulens, Inge, et al.
Publicado: (2010)

Regulation of IL-6 Secretion by Astrocytes via TLR4 in the Fragile X Mouse Model
por: Krasovska, Victoria, et al.
Publicado: (2018)

Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression
por: Jacobs, Shelley, et al.
Publicado: (2010)

Microstructure abnormalities of the diffusion quantities in children with attention-deficit/hyperactivity disorder: an AFQ and TBSS study
por: Hu, Rui, et al.
Publicado: (2023)

Minocycline and MMPs: towards treatment for Fragile X syndrome
Publicado: (2011)

Towards Mechanism-Based Treatments for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Altered Developmental Expression of the Astrocyte-Secreted Factors Hevin and SPARC in the Fragile X Mouse Model
por: Wallingford, Jessica, et al.
Publicado: (2017)

Perceiving and expressing feelings through actions in relation to individual differences in empathic traits: the Action and Feelings Questionnaire (AFQ)
por: Williams, Justin H. G., et al.
Publicado: (2015)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome
por: Siller, Saul S., et al.
Publicado: (2012)

Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A
por: Alusi, Ghassan, et al.
Publicado: (2022)

Event-related potential alterations in fragile X syndrome
por: Knoth, Inga S., et al.
Publicado: (2012)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Fragile X Syndrome in children
por: Acero-Garcés, David O., et al.
Publicado: (2023)

MON-056 Rare X Chromosome Pericentric Inversion Associated with Ovotesticular Disorder of Sex Development
por: Guerra-Junior, Gil, et al.
Publicado: (2020)

Al(x)In(1−x)N on Si (100) Solar Cells (x = 0–0.56) Deposited by RF Sputtering
por: Valdueza-Felip, Sirona, et al.
Publicado: (2020)

Fragile x syndrome and autism: from disease model to therapeutic targets
por: Dölen, Gül, et al.
Publicado: (2009)

Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism
por: Molinaro, Gemma, et al.
Publicado: (2023)

Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
por: Berman, Robert F, et al.
Publicado: (2014)

Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome
por: Maertens, Madison, et al.
Publicado: (2022)

Targeted treatments for fragile X syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2011)

Pathological Plasticity in Fragile X Syndrome
por: Martin, Brandon S., et al.
Publicado: (2012)

Auditory Processing in Fragile X Syndrome
por: Rotschafer, Sarah E., et al.
Publicado: (2014)

Modeling Fragile X Syndrome in Drosophila
por: Drozd, Małgorzata, et al.
Publicado: (2018)

Molecular Biomarkers in Fragile X Syndrome
por: Zafarullah, Marwa, et al.
Publicado: (2019)

Developmental studies in fragile X syndrome
por: Razak, Khaleel A., et al.
Publicado: (2020)

Psychosis and Catatonia in Fragile X Syndrome
por: Keshtkarjahromi, Mitra, et al.
Publicado: (2021)

Hyperexcitability and Homeostasis in Fragile X Syndrome
por: Liu, Xiaopeng, et al.
Publicado: (2022)

An “Omic” Overview of Fragile X Syndrome
por: Dionne, Olivier, et al.
Publicado: (2021)

Chloride imbalance in Fragile X syndrome
por: Miles, Kaleb Dee, et al.
Publicado: (2022)

Closing the Gender Gap in Fragile X Syndrome: Review of Females with Fragile X Syndrome and Preliminary Research Findings
por: Bartholomay, Kristi L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8oo68e8sbme45alhqubha1oi9m